Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
J6 · Effective Oct 1, 2015
24 active Medicare policies list H44.111, and 5 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JE · Effective Oct 8, 2018
JF · Effective Oct 8, 2018
J15 · Effective Oct 1, 2015
5 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of H44.111 |
|---|---|---|
| Extended Ophthalmoscopy | Not recorded | Covered |
| External Ocular Photography | Not recorded | Covered |
| Fluorescein Angiography | Not recorded | Covered |
| Fundus Photography | Not recorded | Covered |
| Policy | Effective | Status of H44.111 |
|---|---|---|
| Fluocinolone Acetonide Intra-vitreal Implant (Retisert, Yutiq and Iluvien) |
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
National · Effective Jan 1, 2026
J6 · Effective Apr 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Sep 3, 2026
National · Effective Oct 1, 2025
J6 · Effective Apr 1, 2026
National · Effective Jun 4, 2026
J9 · Effective Oct 1, 2025
| Jan 5, 2024 |
| Covered |